2016

Pharma Marketing News is periodic e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.

This article summarizes the results of three surveys, which were presented at an FDA Part 15 hearing regarding 'Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products.'

This article summarizes several comments submitted to the FDA in response to the agency's proposed study of animation in direct-to-consumer drug ads.

Instagram may become the social medium of choice for pharma marketers now that it has been purchased by Face-book and has added several new features that allow marketers to potentially thwart FDA regulations.

Welcome to Vol. 15, Issue No. 5 (December 2016) of Pharma Marketing News. This issue focuses on animation in DTC ads, off-label DCTC advertising, and pharma's use of Instagram.

This article summarizes the First Amendment assault on FDA's ability to regulate off-label communications.

This article explores the trend in direct-to-consumer (DTC) ads for 'breakthrough' cancer therapies.

This article describes recent dark and ominous

Welcome to Vol. 15, Issue No. 4 (September 2016) of Pharma Marketing News. This issue focuses on off-label promotions directed to consumers, dark and scary disease awareness advertising, and breakthrough cancer therapy DTC.

This article is a review of the e-book entitled Pharma 3D: Rewriting the script for marketing in the digital age.